# 英国AI临床参考平台（iatroX）的采用情况、可用性及感知临床价值：基于真实世界使用情况的混合方法形成性评估及1223名受访者的用户调查

发布时间：2025年09月25日

`RAG` `医疗健康`

> Adoption, usability and perceived clinical value of a UK AI clinical reference platform (iatroX): a mixed-methods formative evaluation of real-world usage and a 1,223-respondent user survey

# 摘要

> 临床医生正深陷生物医学文献与指南带来的信息洪流，循证诊疗工作因此举步维艰。基于大型语言模型的检索增强生成（RAG）技术虽能快速生成带溯源信息的答案，但仍需真实世界验证。本文介绍了英国本土研发的RAG临床参考平台iatroX，并通过形成性实施评估，报告其早期使用情况、易用性及临床价值感知。

研究方法包括回顾性分析（2025年4月8日至7月31日，共16周）网络端及iOS、Android移动端的使用数据，并开展产品内即时调查。使用数据源自网络与应用分析，并已过滤机器人流量；通过客户端脚本，从预定义问题库（评估有用性、可靠性及使用意愿）中随机抽取题目，向约10%的网络会话用户推送单题调查。百分比结果采用Wilson 95%置信区间描述；自由文本评论则通过主题内容分析法归纳。

使用数据显示，iatroX已吸引19,269名独立网络用户，产生202,660次互动行为及约40,000条临床查询。移动端表现亮眼：iOS下载量达1,960次，Android日活跃用户峰值突破750。调查回收1,223条有效反馈，核心结果如下：感知有用性86.2%（95%置信区间74.8-93.9%；50/58），愿意再次使用93.3%（95%置信区间68.1-99.8%；14/15），会推荐给同事88.4%（95%置信区间75.1-95.9%；38/43），感知准确性75.0%（95%置信区间58.8-87.3%；30/40），可靠性79.4%（95%置信区间62.1-91.3%；27/34）。用户反馈集中在三大优势：响应速度快、答案与指南直接关联、贴合英国临床场景。

早期真实世界应用显示，iatroX有望缓解信息过载，为英国临床医生提供及时解答。本研究局限在于各问题样本量较小且存在早期采用者偏差；未来计划开展准确性审计，并前瞻性研究其对工作流程及护理质量的影响。

> Clinicians face growing information overload from biomedical literature and guidelines, hindering evidence-based care. Retrieval-augmented generation (RAG) with large language models may provide fast, provenance-linked answers, but requires real-world evaluation. We describe iatroX, a UK-centred RAG-based clinical reference platform, and report early adoption, usability, and perceived clinical value from a formative implementation evaluation. Methods comprised a retrospective analysis of usage across web, iOS, and Android over 16 weeks (8 April-31 July 2025) and an in-product intercept survey. Usage metrics were drawn from web and app analytics with bot filtering. A client-side script randomized single-item prompts to approx. 10% of web sessions from a predefined battery assessing usefulness, reliability, and adoption intent. Proportions were summarized with Wilson 95% confidence intervals; free-text comments underwent thematic content analysis. iatroX reached 19,269 unique web users, 202,660 engagement events, and approx. 40,000 clinical queries. Mobile uptake included 1,960 iOS downloads and Android growth (peak >750 daily active users). The survey yielded 1,223 item-level responses: perceived usefulness 86.2% (95% CI 74.8-93.9%; 50/58); would use again 93.3% (95% CI 68.1-99.8%; 14/15); recommend to a colleague 88.4% (95% CI 75.1-95.9%; 38/43); perceived accuracy 75.0% (95% CI 58.8-87.3%; 30/40); reliability 79.4% (95% CI 62.1-91.3%; 27/34). Themes highlighted speed, guideline-linked answers, and UK specificity. Early real-world use suggests iatroX can mitigate information overload and support timely answers for UK clinicians. Limitations include small per-item samples and early-adopter bias; future work will include accuracy audits and prospective studies on workflow and care quality.

[Arxiv](https://arxiv.org/abs/2509.21188)